Core Viewpoint - AVITA Medical, Inc. will present at the Piper Sandler 37th Annual Healthcare Conference on December 4, 2025, at 8:30 a.m. EST, and management will be available for one-on-one meetings with registered investors [1]. Company Overview - AVITA Medical is a leading therapeutic acute wound care company focused on delivering transformative solutions to optimize wound healing and accelerate patient recovery [3]. - The company's flagship product, the RECELL System, is FDA-approved for treating thermal burn and trauma wounds, utilizing the patient's own skin to create Spray-On Skin™ Cells for improved clinical outcomes [3]. - In the U.S., AVITA Medical holds exclusive rights to manufacture and market PermeaDerm, a biosynthetic wound matrix, and Cohealyx™, a collagen-based dermal matrix [3]. International Market Presence - The RECELL System is approved for promoting skin healing in various applications, including thermal burn and trauma wounds, with regulatory clearances in Europe, Australia, and Japan (excluding RECELL GO) [4].

Core Points - Genco Shipping & Trading Limited has received a non-binding indicative proposal from Diana Shipping Inc. to acquire all outstanding shares of Genco not already owned by Diana for $20.60 per share in cash [1] - Diana Shipping currently owns approximately 14.8% of Genco's common stock [1] Company Overview - Genco Shipping & Trading Limited is a U.S.-based drybulk ship owning company focused on the global transportation of commodities, including iron ore, coal, grain, steel products, bauxite, cement, and nickel ore [5] - The company operates a fleet of 45 vessels with an average age of 12.5 years and an aggregate capacity of approximately 5,045,000 deadweight tons (dwt) [5]

Core Viewpoint - First Financial Northwest, Inc. has declared a final cash liquidation distribution of $1.30 per share as part of its Plan of Dissolution, totaling $23.30 per share distributed to shareholders [1][2]. Group 1: Cash Liquidation Distribution - The final cash liquidation distribution will be payable on December 12, 2025, to shareholders of record as of April 23, 2025 [1]. - The total cash distributions to shareholders, including the final distribution, amount to approximately $215 million [2]. Group 2: Shareholder Requirements - Shareholders holding physical stock certificates must convert them to book-entry accounts to receive their cash liquidation distributions [3]. - Georgeson LLC has been retained to assist in locating shareholders who have not responded to previous communications regarding their shares [3]. Group 3: Tax Implications - Cash liquidation distributions will be reported on Form 1099-DIV for the tax year 2025, with U.S. shareholders recognizing gain or loss based on the difference between cash received and their adjusted tax basis [4]. - Long-term capital gains for non-corporate U.S. holders are generally subject to preferential tax rates [4]. Group 4: Company Background - First Financial Northwest, Inc. is the former holding company of First Financial Northwest Bank, which was sold to Global Federal Credit Union on April 11, 2025 [6]. - The company has delisted its common stock from trading on the Nasdaq Capital Market and closed its stock transfer books effective April 21, 2025, as part of its voluntary dissolution [6].

MONTREAL, Nov. 24, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08a technology company driving innovation in advanced materials and critical process development, is pleased to announce that it has closed a non-brokered private placement of 1,883,815 common shares at a price of $0.1625 per share for gross proceeds of $306,120. The financing was completed with a European-based investment firm specializing in tailored, committed, and flexible capital solut ...

Core Insights - Aura Biosciences, Inc. is a clinical-stage biotechnology company focused on developing precision therapies for solid tumors aimed at preserving organ function [3] - The CEO, Elisabet de los Pinos, will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on December 2, 2025 [1] - The company's lead candidate, bel-sar (AU-011), is in late-stage development for early choroidal melanoma and early-stage development for other ocular oncology indications and bladder cancer [3] Company Overview - Aura Biosciences is headquartered in Boston, MA, and aims to grow as an innovative global oncology company that positively transforms patients' lives [3] - The company provides a live webcast of events on its "Investors & Media" page, with replays available for 90 days [2] - Investor relations contact is Alex Dasalla, Head of Investor Relations and Corporate Communications [5]

Core Viewpoint - Exodus Movement, Inc. has announced a definitive agreement to acquire W3C Corp, which includes Monavate and Baanx, to enhance its payments infrastructure and position itself as a leader in on-chain payments [1][2][3] Acquisition Details - The acquisition is valued at $175 million and will be funded through a combination of cash and financing from a credit facility with Galaxy Digital, secured by the company's Bitcoin holdings [7] - The acquisition is subject to regulatory approvals and customary closing conditions, with an expected closing in 2026 [7] Strategic Implications - The acquisition will allow Exodus to control the end-to-end payments experience, integrating issuing, processing, and regulatory capabilities directly into its product suite [3][4] - By bringing card and payments infrastructure in-house, Exodus aims to reduce reliance on third-party providers and support a wider range of assets, including stablecoins [3][4] Market Context - The demand for stablecoin payments has surged, with volumes increasing by 70% from February to August 2025, primarily driven by B2B transactions [4] - The infrastructure expansion is expected to enhance offerings for enterprise clients, enabling flexible payment solutions and partnerships with major players like MetaMask and Ledger [5][6] Financial Outlook - The acquisition is anticipated to diversify Exodus's revenue streams through interchange, processing, and program fees, contributing to a more predictable earnings base [5] - XO Swap, a service offered by Exodus, accounted for 37% of all exchange provider volume in October 2025, indicating strong market presence [5]

Core Insights - PennantPark Floating Rate Capital Ltd. reported its financial results for the fourth quarter and fiscal year ended September 30, 2025, highlighting a stable net investment income and a focus on middle-market investments [1][2]. Financial Performance - For the quarter ended September 30, 2025, the company reported net investment income of $27.5 million, or $0.28 per share, compared to $18.0 million, or $0.24 per share, for the same period in 2024 [19][30]. - The total investment income for the year ended September 30, 2025, was $261.4 million, up from $186.4 million in 2024 [17][30]. - The company declared distributions of $0.31 per share for the quarter and $1.23 per share for the year, totaling $30.5 million and $113.9 million, respectively [30]. Portfolio and Investment Activity - As of September 30, 2025, the investment portfolio totaled $2,773.3 million, consisting of $2,513.6 million in first lien secured debt [8][35]. - The weighted average yield on debt investments was 10.2% at quarter-end [2][8]. - The company invested $633.0 million in the quarter and $1,741.3 million for the year, with a focus on middle-market companies [10][12]. Debt and Liquidity - The company had a credit facility of $683.8 million and a regulatory debt-to-equity ratio of 1.66x as of September 30, 2025 [2][26]. - The annualized weighted average cost of debt was 6.8% for the year ended September 30, 2025, down from 8.5% in 2024 [25][26]. - Cash equivalents available for investing were $122.7 million as of September 30, 2025 [26]. Recent Developments - In August 2025, the company formed a joint venture, PennantPark Senior Secured Loan Fund II, LLC, with a commitment of $200 million to invest in middle-market loans [31]. - The company acquired a portfolio of high-quality assets totaling approximately $250 million, projected to enhance Core NII by one to two cents per share quarterly [32]. - Subsequent to the quarter-end, the company sold $118 million of assets to PSSL and $191 million to PSSL II, using the proceeds to reduce its debt-to-equity ratio to 1.41x [33].

Core Insights - Sana Biotechnology, Inc. is set to present at two investor conferences in December, providing a business overview and updates from CEO Steve Harr [1][5] - The presentations will be accessible via webcast on the company's Investor Relations page, with replays available for 30 days post-conference [2] Company Overview - Sana Biotechnology focuses on creating engineered cells as medicines, aiming to repair and control genes, and replace missing or damaged cells [3] - The company operates in Seattle, WA, Cambridge, MA, and South San Francisco, CA, with a vision to make therapies broadly available to patients [3]

Core Insights - PennantPark Investment Corporation reported its financial results for the fourth quarter and fiscal year ended September 30, 2025, highlighting a decrease in net investment income and net asset value per share compared to the previous year [1][19][23]. Financial Performance - For the year ended September 30, 2025, the company had a net investment income of $46.1 million, or $0.71 per share, down from $60.1 million, or $0.92 per share in the previous year, reflecting a decrease of approximately 23% [19][23]. - The net asset value per share decreased to $7.11 from $7.56, representing a decline of 5.9% [2][32]. - Total investment income for the year was $122.4 million, down from $143.8 million in the prior year [16][35]. Portfolio and Investment Activity - As of September 30, 2025, the investment portfolio totaled $1,287.3 million, with 45% in first lien secured debt and 28% in preferred and common equity [2][6]. - The company made purchases of investments totaling $746.6 million for the year, while sales and repayments amounted to $810.4 million [2][8]. - The weighted average yield on debt investments was 11.0% for the year [2][6]. Expenses and Liabilities - Total expenses for the year were $76.3 million, a decrease from $83.7 million in the previous year, primarily due to lower interest expenses [17][19]. - The company had outstanding borrowings of $426.5 million under the Truist Credit Facility as of September 30, 2025, with a weighted average interest rate of 6.5% [25][26]. Distributions - During the year ended September 30, 2025, the company declared total distributions of $62.7 million, or $0.96 per share, compared to $57.4 million, or $0.88 per share in the previous year [29]. Market Position and Strategy - The company maintains a focus on the core middle market, which is characterized by attractive credit spreads and lower leverage, aiming to support net investment income through realizations of equity holdings [5][37].

Core Insights - Brilliant Earth Group, Inc. is a global leader in ethically sourced fine jewelry and will participate in upcoming investor events [1][2][3] Group 1: Upcoming Investor Events - On December 3, 2025, the Company will participate in NobleCon21, hosting a presentation at 1:00pm ET and holding investor meetings throughout the day [2] - On December 11, 2025, the Company will participate in the KeyBanc Capital Markets Consumer Conference virtually, with a fireside chat at 11:15am ET and additional investor meetings [3] Group 2: Company Overview - Brilliant Earth was founded in 2005 with a mission to create a more transparent, sustainable, and compassionate jewelry industry [4] - The Company reported full year Net Sales of $422 million for 2024 and has achieved positive Adjusted EBITDA for 17 consecutive quarters since going public in 2021 [4] - Brilliant Earth operates 42 showrooms across the United States and serves customers in over 50 countries worldwide [4]